Protein kinase inhibitors 1

CAS No. 1365986-44-2

Protein kinase inhibitors 1( —— )

Catalog No. M17975 CAS No. 1365986-44-2

Protein kinase inhibitors 1 is a novel inhibitor of HIPK2 with an IC50 of 74 nM and Kd of 9.5 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 78 In Stock
10MG 137 In Stock
25MG 304 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Protein kinase inhibitors 1
  • Note
    Research use only, not for human use.
  • Brief Description
    Protein kinase inhibitors 1 is a novel inhibitor of HIPK2 with an IC50 of 74 nM and Kd of 9.5 nM.
  • Description
    Protein kinase inhibitors 1 is a novel inhibitor of HIPK2 with an IC50 of 74 nM and Kd of 9.5 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    HIPK2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1365986-44-2
  • Formula Weight
    383.42
  • Molecular Formula
    C18H17N5O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C4NC(=O)S/C4=C\C=3C=C(c1ccc(nc1)N2CCNCC2)C(=O)NC=3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Miduturu CV, et al. High-throughput kinase profiling: a more efficient approach toward the discovery of new kinaseinhibitors. Chem Biol. 2011 Jul 29;18(7):868-79.
molnova catalog
related products
  • PHYTOSPHINGOSINE

    Phytosphingosine is a phospholipid with anticancer properties. In cancer cells, Phytosphingosine induces cell apoptosis through activation of caspase 8 and translocation of Bax.

  • PBOX 6

    PBOX 6 is a pyrrolo-1,5-benzoxazepine (PBOX) compound exhibiting anticancer and antitumor activity by inhibiting breast cancer cell growth in vitro and selectively inducing apoptosis in leukemia cells through c-Jun NH2 terminal kinase-dependent phosphorylation and inactivation of Bcl-2 and Bcl-XL.

  • Lanperisone HCl

    Lanperisone HCl (NK 433) is a novel orally available centrally acting muscle relaxant with anticancer activity and inhibits mono- and polysynaptic reflex potentials.